Principles of Management of Women with Hirsutism: A Dermatologist’s Perspective
January 2020
in “
Przegla̧d dermatologiczny
”
hirsutism terminal hair androgen-sensitive areas ovarian hyperandrogenism adrenal hyperandrogenism idiopathic hirsutism drug-induced hirsutism endocrinopathies Ferriman-Gallwey visual scoring scale laser hair removal electrolysis combined oral contraception antiandrogens topical eflornithine hair removal oral contraception Vaniqa
TLDR The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.
The document from 2020, "Principles of management of women with hirsutism – a dermatologist’s perspective", discussed hirsutism, a condition characterized by excessive growth of terminal hair in androgen-sensitive areas, affecting 5–15% of women. The condition is primarily caused by ovarian or adrenal hyperandrogenism, but can also be idiopathic, drug-induced, or caused by other endocrinopathies. The severity of hirsutism can be evaluated using a modified Ferriman-Gallwey visual scoring scale. The paper presented various treatment options, including hair removal using lasers or electrolysis, combined oral contraception, antiandrogens, and topical eflornithine. The document provided a clinical scheme for diagnosing and managing hirsutism from a dermatological perspective.
